Regardless of whether you are a PvP player or a PvE player wanting to make an Arc build, this Destiny 2 Sidearm is a must ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.

LLNL is developing a new 3D printing technique to create the millions of fuel capsules needed for fusion power plants.

EMA committee recommends approval of Bristol Myers’ repotrectinib to treat advanced ROS1-positive NSCLC & NTRK-positive solid tumours: Princeton, New Jersey Monday, November 18, ...

Generating electricity with fusion reaction will be possible when the plasma inside stellarators are hot enough, which can be ...

Physicists have been trying to design fusion reactors, technologies that can generate energy via nuclear fusion processes, ...

Boston Pharmaceuticals has linked its metabolic dysfunction-associated steatohepatitis (MASH) prospect to improved outcomes ...

Company remains on track in late-stage, potentially registrational trials of nemvaleukin alfa, with data readouts expected in late Q1/early Q2 ...

Tectonic Therapeutic to present positive phase 1a results of TX45, a long-acting, Fc-relaxin fusion protein at AHA 2024: Watertown, Massachusetts Tuesday, November 12, 2024, 13:00 ...

About TX45, a long-acting Fc-relaxin fusion protein TX45 is an Fc-relaxin fusion protein ... including the ongoing Phase 1b and Phase 2 clinical trials for TX45 in Group 2 PH-HFpEF; and the potential ...

Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...

New hardware boasts significant improvements to reduce noise and generate higher fidelity signals ...